And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, once again, rather modest. We plan to catch up on all sorts of reading, hang with our short person, and forage for valuable sonic treasures at a downsizing event. And what about you? It is never too late to plan a winter break. You might want to catch up on some of those moving pictures you meant to see. Or you could spend all weekend preparing for that football game. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon …

The Philippine government believes that the Sanofi (SNY) dengue vaccine may be connected to three deaths in the country, The Asahi Shimbun writes. Sanofi revealed in November that Dengvaxia, the world’s first dengue vaccine, might increase the risk of severe disease in people who had never been exposed to the virus. Some experts believe at least one other vaccine, which is being developed by Takeda Pharmaceuticals (TKPYY), may see a similar problem when results of its ongoing, eight-country Phase 3 trial are available, STAT explains.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • I have sign up more the once why do USD to sing up so many times. I. Like reading your news I just tone like singing up to menu time’s. Your Friend Rose Dolan.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy